Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre,...

Keywords

CetuximabMedicineRadiation therapyInternal medicineOncologyCisplatinCancerChemotherapyColorectal cancer

Affiliated Institutions

Related Publications

Concomitant cisplatin chemotherapy and radiotherapy in advanced mucosal squamous cell carcinoma of the head and neck. Long-term results of the radiation therapy oncology group study 81-17

Víctor A. Marcial , Thomas F. Pajak , Mohammed Mohiuddin +7 more

One hundred twenty-four eligible patients with advanced mucosal squamous cell carcinoma of the head and neck were entered into a pilot study of concomitant cisplatin (100 mg/m2 ...

1990 Cancer 191 citations

Atezolizumab in combination with carboplatin plus nab-paclitaxel chemotherapy compared with chemotherapy alone as first-line treatment for metastatic non-squamous non-small-cell lung cancer (IMpower130): a multicentre, randomised, open-label, phase 3 trial

Howard West , Michael McCleod , Maen Hussein +17 more

Atezolizumab (a monoclonal antibody against PD-L1), which restores anticancer immunity, improved overall survival in patients with previously treated non-small-cell lung cancer ...

2019 The Lancet Oncology 1597 citations

Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study

Ezra E.W. Cohen , Denis Soulières , Christophe Le Tourneau +97 more

There are few effective treatment options for patients with recurrent or metastatic head-and-neck squamous cell carcinoma. Pembrolizumab showed antitumour activity and manageabl...

2018 The Lancet 1593 citations

Human Papillomavirus Types in Head and Neck Squamous Cell Carcinomas Worldwide: A Systematic Review

Aimée R. Kreimer , Gary M. Clifford , Peter Boyle +1 more

Abstract Mucosal human papillomaviruses (HPV) are the cause of cervical cancer and likely a subset of head and neck squamous cell carcinomas (HNSCC), yet the global prevalence a...

2005 Cancer Epidemiology Biomarkers & Prev... 2129 citations

Survival of squamous cell carcinoma of the head and neck in relation to human papillomavirus infection: Review and meta‐analysis

Camille Ragin , Emanuela Taioli

Abstract Human papillomavirus (HPV) has been associated with head and neck squamous cell carcinomas (HNSCC), especially of the oropharynx, with highest distribution in the tonsi...

2007 International Journal of Cancer 747 citations

Publication Info

Year: 2018
Type: article
Volume: 393
Issue: 10166
Pages: 40-50
Citations: 1218
Access: Closed

External Links

View on DOI.org

Social Impact

Altmetric

Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial

PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

1218

OpenAlex

Cite This

APA Style

                            
                                
                                    Maura L. Gillison, 
                                
                                    Andy Trotti, 
                                
                                    Jonathan Harris
                                
                                et al.
                            
                            (2018). 
                            Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial. 
                            The Lancet
                            , 393
                            (10166)
                            , 40-50.
                            https://doi.org/10.1016/s0140-6736(18)32779-x
                        

Identifiers

DOI: 10.1016/s0140-6736(18)32779-x